Evaluation of carboxytherapy in Striae treatment

Evaluation of carboxytherapy in Striae ?alba and rubra treatment

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140414017271N3

Enrollment

Registered

2018-01-29

Start date

2017-12-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae. Striae atrophicae

Interventions

Intervention group: patients with Striae under treatment with 10 session carboxytherapy every week.

Treatment - Devices

Intervention group: patients with Striae under treatment with 10 session carboxytherapy every week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals with Striae

Exclusion criteria

Exclusion criteria: imaging dissatisfaction Absence of reference in particular time in order to cure and follow up Severe respiratory insufficiency and severe renal insufficiency, chronic renal fail,severe anemia Acute inflamation or skin disease at injection site, inflamatory and infectious involvment of skin such as herpes Poor control diabet Mental weakness,epilepsy Pregnancy and lactation Pationts treated with carbonic anhydrase inhibitors like acetozolamide

Design outcomes

Primary

Measure	Time frame
Diameter of Striae Alba and rubra. Timepoint: every week for 8 weeks and 3 months after treatment. Method of measurement: scoring by 2 dermatologist and patients pleasure according 0-10.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYalda Nahidi

Mashhad University of Medical Sciences

nahidiy@mums.ac.ir+98 51 3802 5732

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026